This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Lazar Bojic, Ph.D.
Vice President of Investor Network at Curie.Bio
Speaker

Profile

Lazar is Head of Investor Network at Curie.Bio. Over the last dozen years, he has served as a basic scientist in large pharma, a biotech co-founder, and a head of corporate development. Lazar has led phenotypic screening and target deconvolution campaigns, played an integral role in taking two agents from an idea into the clinic (one of which is currently in a registrational study for non muscle invasive bladder cancer), and has run point on hundreds of millions of dollars in debt and equity financings. Throughout his career, Lazar has always been at the nexus of business and science. He believes that understanding how to effectively use science to create sound business strategies and communicate those strategies to drive business decisions is vital to the success of a biotech company. Lazar has devoted his career to learning how to effectively navigate both sides of the science and business intersection and is now working with founders of Curie.Bio portfolio companies in helping them raise their Series A.

Agenda Sessions

  • Antibody Therapeutics: Riding the Pendulum of Innovation

    1:15pm